Gateway to Typhoid Conjugate Vaccine Introduction in India and Beyond-Programmatic Effectiveness of a Public Sector Typhoid Conjugate Vaccine Campaign in Navi Mumbai
- PMID: 36947122
- PMCID: PMC10320093
- DOI: 10.1093/cid/ciad134
Gateway to Typhoid Conjugate Vaccine Introduction in India and Beyond-Programmatic Effectiveness of a Public Sector Typhoid Conjugate Vaccine Campaign in Navi Mumbai
Keywords: India; programmatic effectiveness; typhoid conjugate vaccine; vaccine introduction.
Conflict of interest statement
Potential conflicts of interest. The author: No reported conflicts of interest. The author has submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest.
Comment on
-
Programmatic Effectiveness of a Pediatric Typhoid Conjugate Vaccine Campaign in Navi Mumbai, India.Clin Infect Dis. 2023 Jul 5;77(1):138-144. doi: 10.1093/cid/ciad132. Clin Infect Dis. 2023. PMID: 36947143 Free PMC article. Clinical Trial.
References
-
- Global Burden of Disease Collaborative Network . Global Burden of Disease study 2019 (GBD 2019) results. Published 2020. Available at: https://vizhub.healthdata.org/gbd-results/. Accessed 12 February 2023.
-
- Carey ME, Dyson ZA, Ingle DJ, et al. . Global diversity and antimicrobial resistance of typhoid fever pathogens: insights from 13,000 Salmonella Typhi genomes. medRxiv. 22283969 [Preprint]. December 30, 2022. Available from: 10.1101/2022.12.28.22283969. Accessed 12 February 2023. - DOI - PMC - PubMed
